Hemgenix - The First Gene Therapy for Hemophilia B

This week, the GOLD team presents a special episode to mark World AIDS Day, which is taking place on 1st December. Hear from Dr Nneka Nwokolo, Global Head of Patient Affairs, ViiV Healthcare, and Claire Gillis, CEO, VMLY&R Health, as they both discuss HIV stigma, prevention and care in the world today and how pharma can support healthcare professionals and patients. GOLD also speaks to former guest, Laurence Woollard, Director, On the Pulse Consultancy, and haemophilia patient advocate, to get his verdict on the new approval of a first-of-its-kind gene therapy for haemophilia B.

If you're interested in learning more about the topic areas discussed in this episode, check out the following content:

• Access win for HIV patients in sub-Saharan Africa https://www.emg-gold.com/post/access-win-for-hiv-patients-in-sub-saharan-africa
• Monkeypox, misinformation and mitigating a pandemic https://www.emg-gold.com/post/monkeypox-misinformation-and-mitigating-a-pandemic
• Building campaigns with communities https://www.emg-gold.com/post/building-campaigns-with-communities
• Laurence Woollard on challenges facing the haemophilia community https://www.emg-gold.com/post/podcast-digital-solutions-cell-and-gene-therapy-and-haemophilia-in-focus